78
M. Sonneck et al.
Letter
Synlett
(5) (a) Fuchibe, K.; Akiyama, T. J. J. Am. Chem. Soc. 2006, 128, 1434.
(b) Morgan, L. R.; Thangaraj, K.; LeBlanc, B.; Rodgers, A.;
Wolford, L. T.; Hooper, C. L.; Fan, D.; Jursic, B. S. J. Med. Chem.
2003, 46, 4552. (c) Pan, H.-L.; Fletcher, T. L. J. Med. Chem. 1965,
8, 491. (d) Miller, E. C. Cancer Res. 1978, 38, 1479. (e) Robillard,
B.; Lhomme, M. F.; Lhomme, J. Tetrahedron Lett. 1985, 26, 2659.
(f) Fletcher, T. L.; Namkung, M. J.; Pan, H. L. J. Med. Chem. 1967,
10, 936. (g) Doisy, R.; Tang, M. S. Biochemistry 1995, 34, 4358.
(6) (a) Petry, P. J.; Read, M. A.; Davies, R. T.; Gowan, S. M.; Reszka, A.
P.; Wood, A. A.; Kelland, L. R.; Neidle, S. J. Med. Chem. 1999, 42,
2679. (b) Han, Y.; Bisello, A.; Nakamoto, C.; Rosenblatt, M.;
Chorev, M. J. Pept. Res. 2000, 55, 230. (c) Greenlee, M. L.; Laub, J.
B.; Rouen, G. P.; Dininno, F.; Hammond, M. L.; Huber, J. L.;
Sundelof, J. G.; Hammond, G. G. Bioorg. Med. Chem. Lett. 1999, 9,
322. (d) Tierney, M. T.; Grinstaff, M. W. J. Org. Chem. 2000, 65,
5355.
(7) (a) Gould, S. J.; Melville, C. R.; Cone, M. C.; Chen, J.; Carney, J. R.
J. Org. Chem. 1997, 62, 320. (b) Koyama, H.; Kamikawa, T. Tetra-
hedron Lett. 1997, 38, 3973.
(8) Burke, S. M.; Joullie, M. M. Synth. Commun. 1976, 6, 371.
(9) (a) Andrews, E. R.; Fleming, R. W.; Grisar, J. M.; Khim, J. C.;
Wentstrup, D. L.; Mayer, D. J. J. Med. Chem. 1974, 17, 882.
(b) Burke, H. M.; Joullie, M. M. J. Med. Chem. 1978, 21, 1084.
(10) Goel, A.; Chaurasia, S.; Dixit, M.; Kumar, V.; Parakash, S.; Jena,
B.; Verma, J. K.; Jain, M.; Anand, R. S.; Manoharan, S. Org. Lett.
2009, 11, 1289; and references cited therein.
(11) Reim, S.; Lau, M.; Adeel, M.; Hussain, I.; Yawer, M. A.; Riahi, A.;
Ahmed, Z.; Fischer, C.; Reinke, H.; Langer, P. Synthesis 2009, 445.
(12) For reviews of cross-coupling reactions of polyhalogenated het-
erocycles, see: (a) Schröter, S.; Stock, C.; Bach, T. Tetrahedron
2005, 61, 2245. (b) Schnürch, M.; Flasik, R.; Khan, A. F.; Spina,
M.; Mihovilovic, M. D.; Stanetty, P. Eur. J. Org. Chem. 2006, 3283.
(13) For Suzuki–Miyaura reactions of bis(triflates) from our labora-
tory, see, for example: (a) Methyl 2,5-dihydroxybenzoate:
Nawaz, M.; Ibad, M. F.; Abid, O.-U.-R.; Khera, R. A.; Villinger, A.;
Langer, P. Synlett 2010, 150. (b) Alizarin: Mahal, A.; Villinger, A.;
Langer, P. Synlett 2010, 1085 3,4. (c) Dihydroxybenzophenone:
Nawaz, M.; Khera, R. A.; Malik, I.; Ibad, M. F.; Abid, O.-U. R.;
Villinger, A.; Langer, P. Synlett 2010, 979. (d) Phenyl 1,4-dihy-
droxynaphthoate: Abid, O.-U.-R.; Ibad, M. F.; Nawaz, M.; Ali, A.;
Sher, M.; Rama, N. H.; Villinger, A.; Langer, P. Tetrahedron Lett.
2010, 51, 1541. (e) 5,10-Dihydroxy-11H-benzo[b]fluoren-11-
one: Ali, A.; Hussain, M. A.; Villinger, A.; Langer, P. Synlett 2010,
3031.
(C), 136.09 (CH), 133.49 (C), 131.48 (CH), 129.39 (C), 127.62
(CH), 125.70, 124.5, 124.38 (C), 118.85 (q, JF,C = 321.00 Hz, CF3),
118.66 (q, JF,C = 321.00 Hz, CF3). 19F NMR (282 MHz, CDCl3): δ =
–73.02 (CF3), –73.17 (CF3). IR (ATR): ν = 3104.6 (w), 3089 (w),
2921 (w), 2849 (w), 1726 (s), 1427 (s), 1224 (s), 1207 (s), 1166
(m), 1134 (s), 1104 (m), 905 (s), 886 (s), 845 (s), 812 (m), 803
(s), 762 (m), 754 (s), 598 (s) cm–1. MS (EI, 70eV): m/z = 476 (52)
[M+], 343 (13), 279 (100), 251 (49), 223 (35), 185 (14), 154 (16),
128 (33), 100 (12), 69 (43). HRMS (EI): m/z calcd for C15H6F6O7S2
[M+]: 475.94536; found: 475.94491. Anal. Calcd for C15H6F6O7S2
(476.32): C, 37.82; H, 1.27. Found: C, 37.92; H, 1.08.
(15) General Procedure for the Synthesis of 4a–h
In a pressure tube 2 (0,315 mmol), K3PO4 (3.0 equiv), Pd(PPh3)4
(6.0 mol%), and arylboronic acid (2.4 equiv) were mixed with
dry 1,4-dioxane, degassed with argon und stirred for 12 h at
100 °C. After cooling to r.t. the solution was filtered through
Celite, washed with CH2Cl2, and the filtrate was concentrated by
reduced pressure. The residue was purified by column chroma-
tography to receive the bis-substituted fluorenone 4a–h in good
yields.
(16) 1,4-Bis-(3,4-dimethoxyphenyl)-9H-fluoren-9-one (4a)
Starting with 2 (150 mg, 0.315 mmol), 3a (138 mg, 0.756 mmol,
2.4 equiv), Pd(PPh3)4 (22 mg, 0.018 mmol, 6 mol%), K3PO4 (200
mg, 0.945 mmol, 3.0 equiv), and 1,4-dioxane (5 mL). After puri-
fication by column chromatography (silica gel; heptane–EtOAc,
1:1) 4a was isolated as an orange solid (138 mg, 97%); mp 192–
194 °C. 1H NMR (300 MHz, CDCl3): δ = 7.62–7.58 (m, 1 H, ArH),
7.34 (d, J = 7.9 Hz, 1 H, ArH), 7.23 (d, J = 7.9 Hz, 1 H, ArH), 7.21–
7.17 (m, 2 H, ArH), 7.15–7.11 (m, 2 H, ArH), 7.02 (s, 2 H, ArH),
6.97 (d, J = 9.2 Hz, 2 H, ArH), 6.81–6.75 (m, 1 H, ArH), 4.00 (s,
3 H, OCH3), 3.95 (s, 3 H, OCH3), 3.94 (s, 3 H, OCH3), 3.89 (s, 3 H,
OCH3). 13C NMR (75 MHz, CDCl3): δ = 193.09 (CO), 149.35,
149.18, 149.11, 148.43, 143.72, 142.41, 141.17, 136.87 (C),
136.41 (CH), 134.80 (C), 134.20 (CH), 132.29 (C), 131.35 (CH),
130.18 (C), 128.85, 124.03, 123.30, 121.88, 121.20, 113.09,
112.26, 111.57, 110.82 (CH), 56.15, 5615 (OCH3), 56.06, 56.06
(OCH3). IR (ATR): ν = 3008 (w), 2955 (w), 2933 (w), 2905 (w),
2838 (w), 2627 (w), 2577 (w), 1701 (m), 1519 (m), 1441 (s),
1251 (s), 1222 (s), 1146 (s), 1020 (s), 746 (s) cm–1. MS (EI,
70 eV): m/z = 452 (100) [M+], 437 (9), 263 (4); 250 (4), 226 (5),
132 (4). HRMS (ESI-TOF/MS): m/z calcd for C29H24O5 [M + H]+:
453.16965; found: 453.16995; m/z calcd for C29H24O5 [M + Na]+:
475.15159; found: 475.15191.
(17) General Procedure for the Synthesis of 5a–h
(14) Synthesis of 9-Oxo-9H-fluorene-1,4-diaryl-bis(trifluoro-
methanesulfonate) (2)
In a pressure tube 2 (0.525 mmol), K3PO4 (2.0 equiv), Pd(PPh3)4
(3.0 mol%), and arylboronic acid (1.2 equiv) were mixed with
dry 1,4-dioxane, degassed with argon und stirred for 12 h at
60 °C. After cooling to r.t., the solution was filtered through
Celite, washed with CH2Cl2, and the filtrate was concentrated by
reduced pressure. The residue was purified by column chroma-
tography to receive the monosubstituted fluorenone 5a–h in
good yields.
To a CH2Cl2 solution (150 mL) of 1 (1.8 g, 8.543 mmol) was
added dry pyridine (10 mL), and the solution was cooled to
–78 °C under argon atmosphere. Then Tf2O (5.785 g, 20.503
mmol, 2.4 equiv) was added dropwise to the solution and
stirred for 20 h at r.t. After removal of the solvent with reduced
pressure H2O (100 mL) was added to the resulting oil, and the
precipitate was filtered off and recrystallized with hot heptane.
After cooling to r.t., the precipitated pure product 2 was filtered
and washed with heptane. To obtain the residual product, the
heptane was concentrated under vacuum, and the product 2
was isolated by column chromatography (silica gel; heptane–
EtOAc, 3:1) as a yellow fluffy solid (3.318 g, 82%); mp 131–
(18) 1-(4′-Hydroxyphenyl)-9-oxo-9H-fluoren-4-yl-trifluorometh-
anesulfonate (5f)
Starting with 2 (150 mg, 0.315 mmol), 3f (53 mg, 0.378 mmol,
1.2 equiv), Pd(PPh3)4 (11 mg, 0.009 mmol, 3 mol%), K3PO4 (134
mg,0.63 mmol, 2.0 equiv), and 1,4-dioxane (9 mL). After purifi-
cation by column chromatography (silica gel; heptane–EtOAc,
6:1) 5f was isolated as deep yellow solid (112 mg, 86%); mp
194–196 °C. 1H NMR (300 MHz, DMSO): δ = 9.75 (s, 1 H, OH),
7.80–7.69 (m, 2 H, ArH), 7.64 (t, J = 7.2 Hz, 2 H, ArH), 7.51 (t, J =
7.2 Hz, 1 H, ArH), 7.40 (m, 3 H, ArH), 6.83 (d, J = 8.6 Hz, 2 H,
ArH). 13C NMR (63 MHz, CDCl3): δ = 190.03 (CO), 158.21, 142.34,
1
3
133 °C. H NMR (300 MHz, CDCl3): δ = 7.88 (d, J = 7.6 Hz, 1 H,
ArH), 7.78 (d, 3J = 7.4 Hz, 1 H, ArH), 7.64 (dt, 3J = 7.6 Hz, 4J = 1.2
Hz, 1 H, ArH), 7.53 (d, 3J = 9.1 Hz, 1 H, ArH), 7.48 (dt, 3J = 7.5 Hz,
4J = 0.9 Hz, 1 H, ArH), 7.21 (d, 3J = 9.1 Hz, 1 H, ArH). 13C NMR (75
MHz, CDCl3): δ = 187.40 (CO), 144.29, 143.06, 139.32, 138.13
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, 75–79